Colorectal LLM Wiki

Browse
Home / Concepts / Enhanced Recovery After Surgery (ERAS)
Concept created 2026-08-24 · updated 2026-08-27
colorectalERASenhanced-recoveryperioperativequality-improvementtextbookreference

Enhanced Recovery After Surgery (ERAS)

Genuinely new topic for the wiki — no prior page covered enhanced recovery/ERAS as its own subject, though scattered perioperative content exists elsewhere (see Related pages below for how this page connects to it). Content below is from a single specialty textbook reference chapter (ASCRS Ch07 - Optimizing Outcomes with Enhanced Recovery), not primary literature — the chapter itself synthesizes and cites over 100 primary sources, most of which are not independently ingested here.

Origins and overview

Enhanced recovery ("ERAS," "enhanced recovery programs/ERP," "enhanced recovery after surgery") is the application of evidence-based perioperative medicine to minimize surgical stress and optimize recovery. Traces to work by Douglas Wilmore (Boston) and Henrik Kehlet (Copenhagen) in the late 1990s/early 2000s, who identified modifiable sources of perioperative stress (inflammation, sympathetic activation, endocrine activation/insulin resistance, thrombosis/coagulation, cytokine production) and demonstrated that targeted care plans could mitigate them — producing a "lessened dip and faster return to baseline function" recovery curve rather than the prolonged below-baseline trough of traditional perioperative care.

Two parallel trends collided in the early 2000s: Kehlet's perioperative-stress-reduction principles in Scandinavia, and the growth of minimally invasive (laparoscopic) colorectal surgery in the USA (catalyzed by the 2004 COST trial showing laparoscopic colectomy for colon cancer was non-inferior to open surgery). The "ERAS Society" formed in 2007 from a UK-based surgeon-driven implementation effort. By 2008, worldwide improvement in colorectal outcomes (shorter length of stay, fewer wound complications) had been reported by many high-volume laparoscopic centers. UK uptake accelerated after the 2008 recession drove the National Health Service to mandate enhanced recovery for surgical patients, starting with colorectal surgery. In North America, the American Society for Enhanced Recovery (ASER, founded 2014) and the American chapter of the ERAS Society (founded 2017) have driven adoption, though largely via unfunded academic/institutional effort rather than government mandate.

Models of care and the five-phase framework

Enhanced recovery care can be organized either by time/phase (preoperative → intraoperative → postoperative) or by the physiologic stress an intervention targets (multiple interventions can address the same stress point along the surgical continuum). Most implementation frameworks use a five-phase model — preoperative, periop (holding/day-of-surgery), intraoperative, postoperative, and post-discharge — consistent with the American College of Surgeons' Quality Red Book. Each phase is delivered by a different team, and some interventions (e.g., multimodal analgesia, VTE prophylaxis) recur across multiple phases rather than belonging to just one.

Building an enhanced recovery program (ERP) starts with defining target outcomes, creating an evidence library, then implementing via order sets, team education, and administrative support. Champions from surgery, anesthesia, and nursing are essential; pharmacy, IT, nutrition, and administration are important supporting team members.

Preoperative elements

  • Education: patient education/expectation-setting at every phase, ideally at multiple literacy levels (written, spoken, video) — reduces care variability and patient stress.
  • Smoking cessation: even 2-3 weeks of preoperative cessation is beneficial; concerns include anastomotic complications, impaired microcirculation, postoperative pulmonary complications, and IBD-specific considerations. Best-practice resource cited: the American College of Surgeons' "Strong for Surgery" program.
  • Preoperative nutrition: malnutrition is independently associated with worse outcomes and higher cost, and is underdiagnosed — cited figures: roughly 2 of 3 GI surgery patients are malnourished at the time of surgery, only 1 in 5 hospitals have formal nutrition-screening processes, and malnourished patients have roughly 3× the complication risk and 5× the mortality risk of well-nourished patients. PONS score (Perioperative Nutrition Screening) uses BMI, unplanned weight loss, reduced oral intake, and albumin <3.0 to trigger preop nutrition clinic/dietitian referral.
  • Preoperative anemia: a modifiable risk factor, worked up via a stepwise algorithm — hemoglobin threshold (Hb <12 g/dL females, <13 g/dL males) triggers serum ferritin, then iron studies (oral iron if surgery is >6 weeks away, IV iron if <6 weeks), with renal function and B12/folate assessed for non-iron-deficient anemia.
  • Perioperative hyperglycemia: strongly associated with infections, reoperation, and death, but this risk is mitigated by good perioperative insulin management. HbA1c screening per ADA criteria (age >45, diabetes history, PCOS, abnormal fasting glucose, or BMI ≥25 plus a risk factor). Colorectal surgery patients typically have only 2-4 weeks available for optimization before surgery (unlike elective joint replacement, which can delay longer) — a stepwise algorithm triages normal/prediabetic/diabetic HbA1c results to different preop pathways, with a goal perioperative blood sugar <150 mg/dL.
  • Preoperative carbohydrate loading: origin in Ljungqvist's insulin-resistance research — a maltodextrin-containing carbohydrate drink (not carbohydrates from other sources) reduces postoperative insulin resistance and complications, via AMP-activated protein kinase activation. Complements the ASA's guideline permitting clear fluids up to 2 hours before anesthesia induction.
  • Bowel preparation: mechanical bowel prep with oral antibiotics is now recommended for planned lower bowel resections (per the 2019 ASCRS Practice Guidelines Committee) — a reversal from early ERAS Society guidelines, which did not endorse routine mechanical prep; the evidence base has shifted since.

In-hospital preoperative elements

  • PONV prophylaxis: a four-factor risk score (female, non-smoker, prior PONV history, postoperative opioid use) — each factor present is additive (10% baseline, up to ~80% with all four present) and should prompt anesthesia prophylaxis discussion in the preoperative clinic.
  • Multimodal analgesia (MMA): begins preoperatively and continues through discharge — impact of opioid-sparing strategies is significant; even ~10 morphine-equivalent exposure has been associated with increased postoperative ileus risk in colorectal surgery. A published rescue-plan algorithm (ASER-POQI 2) stepwise assesses pain severity/type before escalating to opioid rescue.
  • VTE prophylaxis and antibiotic timing: the chapter defers full detail to Preoperative Evaluation & Perioperative Risk Optimization (its own ASCRS Ch6) — flagged here as a reminder that this content overlaps but is developed in more depth on that page.

Intraoperative elements

  • Multimodal analgesia continues intraoperatively — anesthesia-team-driven, including regional/ neuraxial blocks (epidural, TAP, rectus sheath blocks), lidocaine infusion (evidence for benefit is mixed — a Cochrane review found insufficient evidence to formally recommend it despite favorable single-center reports).
  • Intentional fluid management: three tenets — liberal fluid during bowel prep through 2 hours pre-induction, zero-balance intraoperative fluid management by weight, and reactive (not excessive) IV fluid to maintain normotension/urine output until oral intake resumes. Genuine controversy flagged in the source chapter itself: a large multinational RCT (Myles et al.,

    3000 patients) found higher rates of acute kidney injury with a restrictive intraoperative fluid protocol — but the chapter authors note this trial did not analyze enhanced-recovery elements or preoperative fluid allowance, limiting its direct applicability; a separate Mayo Clinic observational study did not find increased AKI with ERAS-protocol fluid management, though it did find a possible association between higher fluid volumes and increased ileus. The chapter characterizes the evidence for "best" intraoperative fluid management as still accruing.

  • Minimally invasive surgical approaches: reduce surgical stress and are additive to enhanced recovery benefits when combined.
  • Minimal use of drains, tubes, and lines: literature supports no benefit from routine intra-abdominal drains, harm from routine NGT use (except with obstruction), and increased infection/complication risk with central venous access lines.

Postoperative elements

  • Early diet, mobilization, and oral medications: postoperative elements have the largest measured impact on optimal recovery (per an iERAS group review), likely because postoperative compliance is easiest to sustain once earlier-phase elements have already reduced stress. Low residue diet outperforms clear liquid diet for faster return of bowel function and earlier discharge with fewer complications.
  • Multimodal analgesia continues postoperatively with an established rescue-plan algorithm for breakthrough pain.
  • Standard discharge criteria: a five-item international consensus list assessing GI function (tolerance of solid diet, adequate liquid intake), pain management, and activity — objectively confirmed via vital signs, urine output, and spontaneous voiding. A well-run ERP minimizes the gap between meeting discharge criteria and actual discharge (McGill data: readiness and actual discharge both occurred at the expected postoperative day 3 in a rigorous program). Early discharge raises a genuine surveillance concern flagged in Colorectal Anastomotic Complications: up to half of anastomotic leaks present after discharge, and quantified CRP/procalcitonin cutoffs on postop days 3-5 (e.g., CRP <172 mg/L on day 3 has 97% negative predictive value) are proposed there as an evidence-based way to screen for a not-yet-clinically-apparent leak before sending a patient home on an accelerated timeline.

Considerations in special ERAS populations

  • Stoma creation and reversal: diverting ileostomy is a frequent cause of delayed discharge and readmission (high-output/dehydration readmission rates up to 15%). ERAS protocols shorten length of stay for diverted patients even without eliminating this risk, but the expedited discharge timeline leaves less time for patients to learn practical stoma-care skills — many ERAS studies historically excluded stoma-creation patients entirely. A Norwegian RCT found that adding a dedicated ERAS/stoma nurse specialist to preoperative and postoperative stoma education significantly shortened length of stay with no difference in readmission or stoma-related complications versus standard care. See Ileal Pouch-Anal Anastomosis (IPAA) for the diverting loop ileostomy commonly used with IPAA — this page's stoma-education findings are directly applicable to that diversion practice.
  • Emergency surgery and trauma: ERAS is well-established electively but has been studied less in the emergency setting. Compared to elective ERAS-CRS, emergency ERAS is associated with longer length of stay and higher unplanned reoperation rates (without a difference in anastomotic leak or readmission), and overall protocol compliance is lower than in elective cases — but emergency ERAS still confers meaningful benefit (reduced complications, faster return of bowel function, shorter length of stay) compared to emergency surgery without an ERAS program. A 6-protocol/1334-patient meta-analysis confirms this benefit.
  • Elderly patients: ERAS pathways are safe and beneficial in patients >65-70 (shorter hospital stay, fewer complications vs. age-matched standard perioperative care in RCT data), though protocol-item compliance is somewhat lower in the oldest patients (>75-79yo showed the greatest compliance-outcome association in one study, though two later studies did not replicate an adherence-outcome link). Caution is flagged against over-penalizing "non-compliance" that is actually clinically appropriate ineligibility (e.g., a patient on anticoagulation who does not qualify for an epidural is not "non-compliant" with that element). See Preoperative Evaluation & Perioperative Risk Optimization for this wiki's frailty-assessment and elderly perioperative-risk content (RCRI, Hopkins Frailty Score/mFI/RAI, prehabilitation) — that page covers risk stratification in the elderly, this page covers recovery pathway adaptations once a patient is through surgery; complementary, not overlapping content. See also Geriatric Considerations in Colorectal Surgery (ASCRS Ch67) for a dedicated deep-dive that reinforces this section's ERAS-in-elderly findings with rectal-cancer-specific task-force recommendations.
  • Inflammatory bowel disease: IBD patients undergoing colorectal surgery frequently present with malnutrition, immunosuppression, anemia, and intra-abdominal abscesses/fistulas/obstruction, and many IBD operations are less laparoscopy-suitable — raising the question of whether ERAS benefits apply. NSQIP data found IBD diagnosis independently associated with prolonged LOS and higher readmission/morbidity/mortality odds versus non-IBD colectomy patients; a single-institution study found higher postoperative ileus with IBD vs. colorectal cancer patients on the same ERAS protocol (28.8% vs. 14.8%, P<0.001). Despite this, ERAS pathways still measurably benefit IBD patients: pre-/post-ERP studies show reduced SSI, ileus, and anastomotic leak with ERAS implementation for IBD bowel resection, and IBD patients on ERAS have shorter LOS/lower costs than IBD patients on standard perioperative care (though still longer LOS than non-IBD patients on the same protocol) — net benefit, just from a higher baseline-risk starting point. See Crohn Disease and Ulcerative Colitis for disease-specific surgical content; this IBD-and-ERAS finding is general across both diseases and not yet reflected on either page.

Economic impact and future directions

A systematic review/meta-analysis found ERPs save a mean $3,101 USD per patient in colorectal surgery via shorter stay and fewer complications, without increasing readmission rates. Future directions discussed in the chapter: wearable sensors/smart devices for objective postoperative activity monitoring, telemedicine-based postoperative surveillance (shown feasible and associated with early complication detection and reduced ER visits in a French multicenter study), and integration of patient-reported recovery data into electronic health records for research and quality-improvement purposes.

Open items/gaps

  • The chapter's fluid-management controversy (Myles et al. AKI signal vs. Mayo Clinic ileus signal) is presented largely as the chapter authors summarize it — the primary trial data was not independently ingested here.
  • Cost-effectiveness figures ($3,101/patient) are from a single cited systematic review/meta- analysis, not independently verified against the primary studies it pools.
  • No primary literature yet ingested on the ASER-POQI multimodal analgesia rescue algorithm's actual outcome data (only the algorithm structure itself is summarized here).